Creative Planning
IART icon

Creative Planning’s Integra LifeSciences IART Stock Holding History

Creative Planning’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$638K Buy
67,716
+28,645
+73% +$314K ﹤0.01% 2834
2025
Q4 		$485K Buy
39,071
+2,727
+8% +$36.3K ﹤0.01% 2872
2025
Q3 		$521K Buy
36,344
+20,221
+125% +$277K ﹤0.01% 2683
2025
Q2 		$198K Sell
16,123
-1,129
-7% -$16.4K ﹤0.01% 3227
2025
Q1 		$379K Sell
17,252
-1,247
-7% -$29.3K ﹤0.01% 2550
2024
Q4 		$420K Buy
+18,499
New +$404K ﹤0.01% 2390
2023
Q4 		– Sell
-105
Closed -$4.01K – 2913
2023
Q3 		$4.01K Buy
+105
New +$4.42K ﹤0.01% 2745
2017
Q3 		– Sell
-10
Closed -$1K – 2724
2017
Q2 		$1K Buy
+10
New +$478 ﹤0.01% 4445
2013
Q3 		– Sell
-489
Closed -$7K – 3273
2013
Q2 		$7K Buy
+489
New +$7.17K ﹤0.01% 2414

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Creative Planning's IART Position: Q1 2026 in Review

Creative Planning increased its Integra LifeSciences (IART) stake by 73% in Q1 2026, buying an estimated $314K and bringing the position to 67,716 shares worth $638K. The position accounts for ﹤0.01% of the portfolio, ranked #2834.

Creative Planning first reported a position in IART in Q2 2013 and has held it in 9 quarters since. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Creative Planning held 67,716 shares of Integra LifeSciences worth $638K as of Q1 2026.
  • Creative Planning bought 28,645 Integra LifeSciences shares in Q1 2026, an estimated $314K.
  • Integra LifeSciences made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #2834 holding.
  • Creative Planning first reported a position in Integra LifeSciences in Q2 2013 and has held it in 9 quarters since.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.